gms | German Medical Science

102. Jahrestagung der DOG

Deutsche Ophthalmologische Gesellschaft e. V.

23. bis 26.09.2004, Berlin

Tumorous periocular lesions as an indication for systemic diseases

Meeting Abstract

Search Medline for

Evidenzbasierte Medizin - Anspruch und Wirklichkeit. 102. Jahrestagung der Deutschen Ophthalmologischen Gesellschaft. Berlin, 23.-26.09.2004. Düsseldorf, Köln: German Medical Science; 2004. Doc04dogDO.13.09

The electronic version of this article is the complete one and can be found online at:

Published: September 22, 2004

© 2004 Spraul.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.




Ophthalmologists may be considerably involved in making a diagnosis of significant systemic disease and on occasion they may even be the first who assume their presence. With an early diagnosis patients may benefit form an early therapy.


In this paper periocular processes, which are frequently associated with a significant disease are demonstrated. However, only lesions which exhibit a tumorous aspect are included. Not included are processes which are restricted to the bulbus, i.e. phakomatoses.


The lesions may be grouped into xanthomatous (e.g. Tuberous Xanthomas), xanthogranulomatous (e.g. Necrobiotic Xanthogranulom with Paraproteinaemia, Erdheim Chester disease), histiocytous (e.g. Langerhans Cell Histiozytosis), infectious (e.g. Sarcoidosis, Leprosy), neoplastistic (Kaposi`s Sarcoma, lymphomas, as well as metastases) and other lesions (e.g. Sebaceous adenoma, keratoakanthoma, Rosai-Dorfman syndrome, Giant cell Polymyositis, Carney`s complex, actinic Granuloma, Calcinosis cutis, Lipoidproteinosis and lymphomatoide Granulomatosis.)


The presence of one of these periocular processes mentioned should lead to a systemic evaluation, in order not to miss an underlying systemic disease and initiate a proper treatment.